Neonatal vitamin D status and risk of multiple sclerosis
A population-based case-control study
Citation Manager Formats
Make Comment
See Comments
This article requires a subscription to view the full text. If you have a subscription you may use the login form below to view the article. Access to this article can also be purchased.
Abstract
Objective: As previous research has suggested that exposure to vitamin D insufficiency in utero may have relevance for the risk of multiple sclerosis (MS), we aimed to examine the direct association between level of neonatal vitamin D and risk of MS.
Methods: We carried out a matched case-control study. Dried blood spots samples (DBSS) belonging to 521 patients with MS were identified in the Danish Newborn Screening Biobank. For every patient with MS, 1–2 controls with the same sex and birth date were retrieved from the Biobank (n = 972). Level of 25-hydroxyvitamin D (25[OH]D) in the DBSS was measured using liquid chromatography tandem mass spectroscopy. The association between different levels of 25(OH)D and risk of MS was evaluated by odds ratios (OR) calculated in conditional logistic regression models.
Results: We observed that lower levels of 25(OH)D in neonates were associated with an increased risk of MS. In the analysis by quintiles, MS risk was highest among individuals in the bottom quintile (<20.7 nmol/L) and lowest among those in the top quintile of 25(OH)D (≥48.9 nmol/L), with an OR for top vs bottom of 0.53 (95% confidence interval [CI] 0.36–0.78). In the analysis treating 25(OH)D as a continuous variable, a 25 nmol/L increase in neonatal 25(OH)D resulted in a 30% reduced risk of MS (OR 0.70, 95% CI 0.57–0.84).
Conclusion: Low concentrations of neonatal vitamin D are associated with an increased risk of MS. In light of the high prevalence of vitamin D insufficiency among pregnant women, our observation may have importance for public health.
GLOSSARY
- 25(OH)D=
- 25-hydroxyvitamin D;
- 25(OH)D2=
- 25-hydroxyvitamin D2;
- 25(OH)D3=
- 25-hydroxyvitamin D3;
- CI=
- confidence interval;
- DBSS=
- dried blood spots samples;
- DNSB=
- Danish Newborn Screening Biobank;
- MS=
- multiple sclerosis;
- OR=
- odds ratio
Footnotes
↵* These authors contributed equally to this study and should be considered as co–first authors.
↵‡ These authors contributed equally to this study and should be considered as co–last authors.
Go to Neurology.org for full disclosures. Funding information and disclosures deemed relevant by the authors, if any, are provided at the end of the article.
Supplemental data at Neurology.org
Editorial, page 13
- Received April 1, 2016.
- Accepted in final form August 24, 2016.
- © 2016 American Academy of Neurology
AAN Members
We have changed the login procedure to improve access between AAN.com and the Neurology journals. If you are experiencing issues, please log out of AAN.com and clear history and cookies. (For instructions by browser, please click the instruction pages below). After clearing, choose preferred Journal and select login for AAN Members. You will be redirected to a login page where you can log in with your AAN ID number and password. When you are returned to the Journal, your name should appear at the top right of the page.
AAN Non-Member Subscribers
Purchase access
For assistance, please contact:
AAN Members (800) 879-1960 or (612) 928-6000 (International)
Non-AAN Member subscribers (800) 638-3030 or (301) 223-2300 option 3, select 1 (international)
Sign Up
Information on how to subscribe to Neurology and Neurology: Clinical Practice can be found here
Purchase
Individual access to articles is available through the Add to Cart option on the article page. Access for 1 day (from the computer you are currently using) is US$ 39.00. Pay-per-view content is for the use of the payee only, and content may not be further distributed by print or electronic means. The payee may view, download, and/or print the article for his/her personal, scholarly, research, and educational use. Distributing copies (electronic or otherwise) of the article is not allowed.
Letters: Rapid online correspondence
- Author response to Dr. Zarghami and Xia et al.
- Nete Munk Nielsen, Researcher, Department of Epidemiology Research, Statens Serum Institut, Copenhagen, DenmarkNMN@ssi.dk
- Kassandra L. Munger, Boston; Egon Stenager, Odense, Denmark; Alberto Ascherio, Boston
Submitted April 27, 2017 - Vitamin D supplementation for the prevention and treatment of MS
- Zhiwei Xia, Department of Neurology, Xiangya Hospital, Central South Universityxiazhiwei2011@gmail.com
- Quan Cheng, Jing Li, Changsha, Hunan, China
Submitted January 30, 2017 - Multiple sclerosis and the independent roles of vitamin D and sun exposure
- Amin Zarghami, Researcher, Department of Neurology, Babol University of Medical Sciences, Babol, Iran; Chancellor for Healaminzarghami18@yahoo.com
Submitted January 04, 2017
REQUIREMENTS
You must ensure that your Disclosures have been updated within the previous six months. Please go to our Submission Site to add or update your Disclosure information.
Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.
If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.
Submission specifications:
- Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
- Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
- Submit only on articles published within 6 months of issue date.
- Do not be redundant. Read any comments already posted on the article prior to submission.
- Submitted comments are subject to editing and editor review prior to posting.
You May Also be Interested in
Dr. Deborah Friedman and Dr. Stacy Smith
► Watch
Related Articles
Topics Discussed
Alert Me
Recommended articles
-
Article
25-Hydroxyvitamin D deficiency and risk of MS among women in the Finnish Maternity CohortKassandra L. Munger, Kira Hongell, Julia Åivo et al.Neurology, September 13, 2017 -
Article
Association between age at onset of multiple sclerosis and vitamin D level–related factorsJulie Hejgaard Laursen, Helle Bach Søndergaard, Per Soelberg Sørensen et al.Neurology, October 07, 2015 -
Article
Evidence for a causal relationship between low vitamin D, high BMI, and pediatric-onset MSMilena A. Gianfrancesco, Pernilla Stridh, Brooke Rhead et al.Neurology, March 29, 2017 -
Article
Sun exposure over the life course and associations with multiple sclerosisHelen Tremlett, Feng Zhu, Alberto Ascherio et al.Neurology, March 07, 2018